Novel T cells with improved in vivo anti-tumor activity generated by RNA electroporation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel T cells with improved in vivo anti-tumor activity generated by RNA electroporation
Authors
Keywords
T lymphocytes, CAR, manufacture, gene transfer, RNA electroporation
Journal
Protein & Cell
Volume 8, Issue 7, Pages 514-526
Publisher
Springer Nature
Online
2017-05-19
DOI
10.1007/s13238-017-0422-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- T memory stem cells in health and disease
- (2017) Luca Gattinoni et al. NATURE MEDICINE
- Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies
- (2016) M. Sabatino et al. BLOOD
- Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
- (2016) Jiangtao Ren et al. CLINICAL CANCER RESEARCH
- Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice
- (2015) X. Liu et al. CANCER RESEARCH
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Adoptive Immunotherapy for Cancer or Viruses
- (2014) Marcela V. Maus et al. Annual Review of Immunology
- Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapy
- (2014) David M. Barrett et al. CYTOTHERAPY
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- (2013) R. J. Brentjens et al. Science Translational Medicine
- Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails
- (2012) Shicheng Yang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
- (2012) Christopher C Kloss et al. NATURE BIOTECHNOLOGY
- Ex Vivo Expansion of Human CD8+ T Cells Using Autologous CD4+ T Cell Help
- (2012) Marcus O. Butler et al. PLoS One
- Treatment of Advanced Leukemia in Mice with mRNA Engineered T Cells
- (2011) David M. Barrett et al. HUMAN GENE THERAPY
- A human memory T cell subset with stem cell–like properties
- (2011) Luca Gattinoni et al. NATURE MEDICINE
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor
- (2010) Y. Zhao et al. CANCER RESEARCH
- Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients
- (2010) M. J. Besser et al. CLINICAL CANCER RESEARCH
- A Simplified Method for the Clinical-scale Generation of Central Memory-like CD8+ T Cells After Transduction With Lentiviral Vectors Encoding Antitumor Antigen T-cell Receptors
- (2010) Shicheng Yang et al. JOURNAL OF IMMUNOTHERAPY
- Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
- (2009) C. Carpenito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overcoming obstacles to the effective immunotherapy of human cancer
- (2008) S. A. Rosenberg PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now